lenvatinib and Skin-Ulcer

lenvatinib has been researched along with Skin-Ulcer* in 2 studies

Reviews

1 review(s) available for lenvatinib and Skin-Ulcer

ArticleYear
Multiple lenvatinib-associated skin ulcers: A case report and literature review.
    The Australasian journal of dermatology, 2023, Volume: 64, Issue:4

    Topics: Antineoplastic Agents; Humans; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; Skin Ulcer; Thyroid Neoplasms

2023

Other Studies

1 other study(ies) available for lenvatinib and Skin-Ulcer

ArticleYear
Severe skin ulcer caused by taking lenvatinib after proton beam therapy.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:4

    A 69-year-old man was treated with lenvatinib after three sessions of proton beam therapy (PBT) for hepatocellular carcinoma. Five months after administration of lenvatinib, a dermatitis with huge skin ulcer formed in the site of PBT irradiation. Lenvatinib was immediately withdrawn, but the skin ulcer continued growing until about 2 weeks later. With topical and antibiotic treatment, the skin ulcer resolved after about 4 months. After administration of lenvatinib, potential skin damage due to PBT at the irradiated site may have become apparent. This is the first report describing skin ulcer by the combination of lenvatinib administration and PBT.

    Topics: Aged; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Proton Therapy; Skin Ulcer

2023